Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15897985rdf:typepubmed:Citationlld:pubmed
pubmed-article:15897985lifeskim:mentionsumls-concept:C0019351lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0206558lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0376358lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0027775lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0205473lld:lifeskim
pubmed-article:15897985lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:15897985pubmed:issue12lld:pubmed
pubmed-article:15897985pubmed:dateCreated2005-5-17lld:pubmed
pubmed-article:15897985pubmed:abstractTextSexual history has consistently been found to be a risk factor for the development of prostate cancer. An association between prostate cancer and herpes simplex virus type 2 (HSV-2) or Kaposi sarcoma-associated herpesvirus/human herpesvirus type 8 (HHV-8) infections has also been reported. Linkage of data on a cohort of 20,243 healthy Finnish men identified 165 cases of prostate cancer that were diagnosed up to 24 years after donation of a serum sample. Two control subjects were matched by age, sex, and municipality of residence to each case patient. Serum levels of immunoglobulin G against HSV-2 and HHV-8 were determined. Neither HSV-2 infection (odds ratio [OR], 0.93 [95% confidence interval {CI}, 0.44-1.96]) nor HHV-8 infection (OR, 0.74 [95% CI, 0.19-2.88]) was associated with prostate cancer.lld:pubmed
pubmed-article:15897985pubmed:languageenglld:pubmed
pubmed-article:15897985pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15897985pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15897985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15897985pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15897985pubmed:statusMEDLINElld:pubmed
pubmed-article:15897985pubmed:monthJunlld:pubmed
pubmed-article:15897985pubmed:issn0022-1899lld:pubmed
pubmed-article:15897985pubmed:authorpubmed-author:DillnerJoakim...lld:pubmed
pubmed-article:15897985pubmed:authorpubmed-author:WangXiaohongXlld:pubmed
pubmed-article:15897985pubmed:authorpubmed-author:KnektPaulPlld:pubmed
pubmed-article:15897985pubmed:authorpubmed-author:TedeschiRosam...lld:pubmed
pubmed-article:15897985pubmed:authorpubmed-author:KorodiZoltanZlld:pubmed
pubmed-article:15897985pubmed:issnTypePrintlld:pubmed
pubmed-article:15897985pubmed:day15lld:pubmed
pubmed-article:15897985pubmed:volume191lld:pubmed
pubmed-article:15897985pubmed:ownerNLMlld:pubmed
pubmed-article:15897985pubmed:authorsCompleteYlld:pubmed
pubmed-article:15897985pubmed:pagination2008-11lld:pubmed
pubmed-article:15897985pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:meshHeadingpubmed-meshheading:15897985...lld:pubmed
pubmed-article:15897985pubmed:year2005lld:pubmed
pubmed-article:15897985pubmed:articleTitleNo serological evidence of association between prostate cancer and infection with herpes simplex virus type 2 or human herpesvirus type 8: a nested case-control study.lld:pubmed
pubmed-article:15897985pubmed:affiliationDepartment of Medical Microbiology, Lund University, University Hospital, Malmo, Sweden.lld:pubmed
pubmed-article:15897985pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15897985pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15897985lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15897985lld:pubmed